Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Safety and Efficacy of Mucinex D for Symptomatic Therapy in Patients With Acute Upper Respiratory Tract Who Seek Treatment
The purpose of this study is to determine if treatment with Mucinex D lowers the use of antibiotics in the treatment of upper respiratory infection when compared to placebo
Age
18 - 75 years
Sex
ALL
Healthy Volunteers
No
Clinical Research Advantage, Inc.
Mesa, Arizona, United States
Med Center
Carmichael, California, United States
Research Center of Fresno, 3636 N. First Street, Suite 141
Fresno, California, United States
Coastal Medical Research Group, Inc., 47 Santa Rosa Street
San Luis Obispo, California, United States
Coastal Connecticut Research, LLC, 342 Montauk Avenue
New London, Connecticut, United States
Glasgow Family Practice
Newark, Delaware, United States
Koch Family Medicine, 81A E. Queenwood Road
Morton, Illinois, United States
Sterling Research Group, Ltd., 650 Sprucewood Lane
Erlanger, Kentucky, United States
Clinical Associates Research, 750 Main Street, Suite 310
Reisterstown, Maryland, United States
Park Place Family Practice & Internal Medicine
Taylor, Michigan, United States
Start Date
October 1, 2009
Primary Completion Date
April 1, 2010
Completion Date
July 1, 2010
Last Updated
December 30, 2020
1,179
ACTUAL participants
Guaifenesin
DRUG
Placebo
DEVICE
Lead Sponsor
Reckitt Benckiser Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions